Dr Reddys Laboratories launches Bivalirudin for Injection
In US market
Dr Reddy's Laboratories has launched Bivalirudin for Injection, 250 mg/vial, a therapeutic equivalent generic version of Angiomax (Bivalirudin) for Injection, approved by the USFDA.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content